Antibodies, Antiphospholipid
"Antibodies, Antiphospholipid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Autoantibodies directed against phospholipids. These antibodies are characteristically found in patients with systemic lupus erythematosus (LUPUS ERYTHEMATOSUS, SYSTEMIC;), ANTIPHOSPHOLIPID SYNDROME; related autoimmune diseases, some non-autoimmune diseases, and also in healthy individuals.
MeSH Number(s)
D12.776.124.486.485.114.323.210
D12.776.124.790.651.114.323.210
D12.776.377.715.548.114.323.210
Below are MeSH descriptors whose meaning is more general than "Antibodies, Antiphospholipid".
Below are MeSH descriptors whose meaning is more specific than "Antibodies, Antiphospholipid".
This graph shows the total number of publications written about "Antibodies, Antiphospholipid" by people in Harvard Catalyst Profiles by year, and whether "Antibodies, Antiphospholipid" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 0 | 1 | 1 |
| 1994 | 1 | 0 | 1 |
| 1995 | 0 | 1 | 1 |
| 1996 | 3 | 1 | 4 |
| 1998 | 4 | 0 | 4 |
| 1999 | 1 | 1 | 2 |
| 2000 | 2 | 0 | 2 |
| 2001 | 1 | 1 | 2 |
| 2002 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2007 | 1 | 1 | 2 |
| 2008 | 0 | 4 | 4 |
| 2009 | 1 | 1 | 2 |
| 2011 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 3 | 0 | 3 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 2 | 3 |
| 2018 | 2 | 1 | 3 |
| 2019 | 1 | 2 | 3 |
| 2020 | 2 | 0 | 2 |
| 2021 | 0 | 1 | 1 |
| 2022 | 0 | 2 | 2 |
Below are the most recent publications written about "Antibodies, Antiphospholipid" by people in Profiles.
-
Predictors of Recurrent Venous Thrombosis After Cerebral Venous Thrombosis: Analysis of the ACTION-CVT Study. Neurology. 2022 11 22; 99(21):e2368-e2377.
-
The effect of the BNT162b2 vaccine on antinuclear antibody and antiphospholipid antibody levels. Immunol Res. 2022 12; 70(6):800-810.
-
Antiphospholipid antibodies and the risk of autoimmune hemolytic anemia in patients with systemic lupus erythematosus: A systematic review and meta-analysis. Autoimmun Rev. 2022 Jan; 21(1):102913.
-
Impaired B cell anergy is not sufficient to breach tolerance to nuclear antigen in V?8/3H9 lupus-prone mice. PLoS One. 2020; 15(7):e0236664.
-
[Management of the antiphospholipid syndrome in adults]. Rev Med Suisse. 2020 Apr 08; 16(689):670-674.
-
Membranous Nephropathy Posttransplantation: An Update of the Pathophysiology and Management. Transplantation. 2019 10; 103(10):1990-2002.
-
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019 09; 71(9):1400-1412.
-
Antiphospholipid score is a novel risk factor for idiopathic osteonecrosis of the femoral head in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2019 04 01; 58(4):645-649.
-
Circulating plasmablasts contribute to antiphospholipid antibody production, associated with type I interferon upregulation. J Thromb Haemost. 2019 07; 17(7):1134-1143.
-
The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository. Arthritis Care Res (Hoboken). 2019 01; 71(1):134-141.